These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 36618343)

  • 1. Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population-based analysis.
    Zhao J; Li D; Xie S; Deng X; Wen X; Li J; Wu Z; Yang X; Li M; Tang Y; Zhang X; Ding Y
    Front Immunol; 2022; 13():1083840. PubMed ID: 36618343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram for predicting survival after first-line anti-PD-1-based immunotherapy in unresectable stage IV melanoma: a multicenter international study.
    Chatziioannou E; Higuita LMS; Kreft S; Kandolf L; Dujovic B; Reinhardt L; Tamara E; Marquez-Rodas I; Fortuna ARFP; Nübling A; Niessner H; Forschner A; Garbe C; Popovic A; Mirjana B; Meier F; Eigentler T; Leiter U; Flatz L; Sinnberg T; Amaral T
    ESMO Open; 2024 Aug; 9(8):103661. PubMed ID: 39096893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of prognostic factors and nomogram model for patients with advanced lung cancer receiving immune checkpoint inhibitors.
    Chen X; Li Z; Zhou J; Wei Q; Wang X; Jiang R
    PeerJ; 2022; 10():e14566. PubMed ID: 36540802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a nomogram based on common biochemical indicators for survival prediction of children with high-risk neuroblastoma: A valuable tool for resource-limited hospitals.
    Wu R; Li X; Chen Z; Shao Q; Zhang X; Tang W; Hu B
    BMC Pediatr; 2023 Aug; 23(1):426. PubMed ID: 37633889
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram Based on Liver Function Test Indicators for Survival Prediction in Nasopharyngeal Carcinoma Patients Receiving PD-1 Inhibitor Therapy.
    Liang L; Li Y; Hong Y; Ji T; Chen H; Lin Z
    Curr Oncol; 2023 Jul; 30(8):7189-7202. PubMed ID: 37623002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients.
    Basak EA; van der Meer JWM; Hurkmans DP; Schreurs MWJ; Oomen-de Hoop E; van der Veldt AAM; Bins S; Joosse A; Koolen SLW; Debets R; Peeters RP; Aerts JGJV; Mathijssen RHJ; Medici M
    Thyroid; 2020 Jul; 30(7):966-973. PubMed ID: 32151195
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma.
    Pires da Silva I; Ahmed T; McQuade JL; Nebhan CA; Park JJ; Versluis JM; Serra-Bellver P; Khan Y; Slattery T; Oberoi HK; Ugurel S; Haydu LE; Herbst R; Utikal J; Pföhler C; Terheyden P; Weichenthal M; Gutzmer R; Mohr P; Rai R; Smith JL; Scolyer RA; Arance AM; Pickering L; Larkin J; Lorigan P; Blank CU; Schadendorf D; Davies MA; Carlino MS; Johnson DB; Long GV; Lo SN; Menzies AM
    J Clin Oncol; 2022 Apr; 40(10):1068-1080. PubMed ID: 35143285
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic nomogram for patients with Nasopharyngeal Carcinoma incorporating hematological biomarkers and clinical characteristics.
    Li J; Chen S; Peng S; Liu Y; Xing S; He X; Chen H
    Int J Biol Sci; 2018; 14(5):549-556. PubMed ID: 29805306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Mortality of Patients with Initially Diagnosed Metastatic Cutaneous Melanoma.
    Li W; Xiao Y; Xu X; Zhang Y
    Ann Surg Oncol; 2021 Jul; 28(7):3490-3500. PubMed ID: 33191484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy.
    Gou M; Qian N; Zhang Y; Wei L; Fan Q; Wang Z; Dai G
    Front Immunol; 2022; 13():950868. PubMed ID: 36225924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition.
    Heppt MV; Heinzerling L; Kähler KC; Forschner A; Kirchberger MC; Loquai C; Meissner M; Meier F; Terheyden P; Schell B; Herbst R; Göppner D; Kiecker F; Rafei-Shamsabadi D; Haferkamp S; Huber MA; Utikal J; Ziemer M; Bumeder I; Pfeiffer C; Schäd SG; Schmid-Tannwald C; Tietze JK; Eigentler TK; Berking C
    Eur J Cancer; 2017 Sep; 82():56-65. PubMed ID: 28648699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and Validation of a Prediction Model for Thyroid Dysfunction in Patients During Immunotherapy.
    Wang Q; Wu T; Zhao R; Li Y; Chen X; Shen S; Zhang X
    Endocr Pract; 2024 Oct; 30(10):943-950. PubMed ID: 39004306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a gene expression-based signature to predict distant metastasis in locoregionally advanced nasopharyngeal carcinoma: a retrospective, multicentre, cohort study.
    Tang XR; Li YQ; Liang SB; Jiang W; Liu F; Ge WX; Tang LL; Mao YP; He QM; Yang XJ; Zhang Y; Wen X; Zhang J; Wang YQ; Zhang PP; Sun Y; Yun JP; Zeng J; Li L; Liu LZ; Liu N; Ma J
    Lancet Oncol; 2018 Mar; 19(3):382-393. PubMed ID: 29428165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma.
    Tian M; Yang J; Han J; He J; Liao W
    Int Immunopharmacol; 2020 Oct; 87():106821. PubMed ID: 32731180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An immune risk score with potential implications in prognosis and immunotherapy of metastatic melanoma.
    Sheng Y; Tong L; Geyu L
    Int Immunopharmacol; 2020 Nov; 88():106921. PubMed ID: 32871477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalised medicine: Development and external validation of a prognostic model for metastatic melanoma patients treated with ipilimumab.
    Valpione S; Martinoli C; Fava P; Mocellin S; Campana LG; Quaglino P; Ferrucci PF; Pigozzo J; Astrua C; Testori A; Chiarion-Sileni V
    Eur J Cancer; 2015 Sep; 51(14):2086-94. PubMed ID: 26227432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel nomogram for predicting prognosis of North Chinese with autoimmune cerebellar ataxia.
    Zhao C; Jiang C; Tian D; Yao Y; Song T; Wang H; Xu W
    Ann Med; 2024 Dec; 56(1):2407057. PubMed ID: 39329327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of nomograms predicting survival in Chinese patients with triple negative breast cancer.
    Yang Y; Wang Y; Deng H; Tan C; Li Q; He Z; Wei W; Zhou E; Liu Q; Liu J
    BMC Cancer; 2019 Jun; 19(1):541. PubMed ID: 31170946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S100B and LDH as early prognostic markers for response and overall survival in melanoma patients treated with anti-PD-1 or combined anti-PD-1 plus anti-CTLA-4 antibodies.
    Wagner NB; Forschner A; Leiter U; Garbe C; Eigentler TK
    Br J Cancer; 2018 Aug; 119(3):339-346. PubMed ID: 29950611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.